ACMR Stock Surges 35% With A 7-day Winning Spree On Zacks Upgrade
ACM Research (ACMR) stock hit day 7-day winning streak, with cumulative gains over this period amounting to a 35%. The company market cap has surged by about $896 Mil over the last 7 days, and currently stands at $3.4 Bil.
The stock has YTD (year-to-date) return of 35.3% compared to 1.9% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity, or a trap.
What Triggered The Rally?
[1] Zacks Analyst Upgrade
- Earn 11% Today or Buy LULU 30% Cheaper – It’s a Win-Win
- Triggers That Could Ignite the Next Rally In Advanced Micro Devices Stock
- The Hidden Dangers Facing Tesla Stock
- PagerDuty Stock: Strong Cash Flow Poised for a Re-Rating?
- High Margins, 39% Discount: Buy Salesforce Stock Now
- Ten-Year Tally: Alphabet Stock Delivers $357 Bil Gain
- Rating Raised From ‘Strong Sell’ To ‘Hold’
- Part Of Broader Semiconductor Sector Breakout
- Impact: Shift In Analyst Sentiment, Stock Hit New 52-Week High
Opportunity or Trap?
Below is our take on valuation.
There is not much to fear in ACMR stock given its overall Strong operating performance and financial condition. This is aligned with the stock’s High valuation because of which we think it is Fairly Priced (For details, see Buy or Sell ACMR).
But here is the real interesting point.
You are reading about this 35% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that haven not surged yet.
Returns vs S&P 500
The following table summarizes the return for ACMR stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | ACMR | S&P 500 |
|---|---|---|
| 1D | 0.3% | 0.2% |
| 7D (Current Streak) | 35.3% | 1.9% |
| 1M (21D) | 35.2% | 1.3% |
| 3M (63D) | 45.8% | 6.5% |
| YTD 2026 | 35.3% | 1.9% |
| 2025 | 161.3% | 16.4% |
| 2024 | -22.7% | 23.3% |
| 2023 | 153.4% | 24.2% |
However, big gains can follow sharp reversals – but how has ACMR behaved after prior drops? See ACMR Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 96 S&P constituents with 3 days or more of consecutive gains and 22 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 79 | 15 |
| 4D | 8 | 6 |
| 5D | 3 | 1 |
| 6D | 3 | 0 |
| 7D or more | 3 | 0 |
| Total >=3 D | 96 | 22 |
Key Financials for ACM Research (ACMR)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $557.7 Mil | $782.1 Mil |
| Operating Income | $95.8 Mil | $151.0 Mil |
| Net Income | $77.3 Mil | $103.6 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $215.4 Mil | $269.2 Mil |
| Operating Income | $31.7 Mil | $28.9 Mil |
| Net Income | $29.8 Mil | $35.9 Mil |
While ACMR stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.